Last updated on: 10/31/2007 | Author: ProCon.org

Unimed Pharmaceuticals Biography

Position:
None Found to the question "Should Marijuana Be a Medical Option?"
Reasoning:

No position found as of Oct. 31, 2007

Theoretical Expertise Ranking:
  Organizations/VIPs/Others
Individuals and organizations that do not fit into the other star categories.
Description:

“Unimed Pharmaceuticals, Inc., a wholly owned subsidiary of Solvay Pharmaceuticals, Inc., focuses on drugs with multiple indications in the therapeutic areas of men’s health, HIV and other infectious diseases. Unimed Pharmaceuticals has expertise in ethical drug development, marketing and sales. In July 1999, Solvay Pharmaceuticals, Inc. acquired Unimed. It is a member of the worldwide Solvay Group of chemical and pharmaceutical companies, headquartered in Brussels, Belgium.”

“Corporate Overview,” Unimed website (accessed Oct. 31, 2007)

Mission:

“Unimed Pharmaceuticals, Inc. announced…that effective January 1, 2001, it has become solely responsible for the marketing of Marinol® CIII (dronabinol) capsules. Marinol® is the only FDA approved synthetic form of tetrahydrocannabinol (THC).”

“News Room,” Solvay Pharmaceuticals website (accessed Oct. 31, 2007)

Other:
Corporation
Quoted in:
  1. What Is Marinol?